MRGPRX2 and asthma: These ligands can activate tissue-resident mast cells to amplify inflammation, and consequently, mast cells play a pivotal role in mediating the pathophysiology of chronic diseases such as urticaria (5), asthma (6), and rosacea (15), which involve the over-production of the MRGPRX2 ligands.